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CObjectives: The objective of the present study was to measure and
compare the direct costs of intensive care unit (ICU) days at seven ICU
departments in Germany, Italy, the Netherlands, and the United King-
dom by means of a standardized costing methodology. Methods: A
retrospective cost analysis of ICU patients was performed from the
hospital’s perspective. The standardized costing methodology was de-
veloped on the basis of the availability of data at the seven ICU depart-
ments. It entailed the application of the bottom–up approach for “hotel
and nutrition” and the top–down approach for “diagnostics,” “consum-
ables,” and “labor.”Results: Direct costs per ICU day ranged from €1168
to €2025. Even though the distribution of costs varied by cost compo- O
o rep
al Te
al So
doi:10.1016/j.jval.2011.09.007ent, labor was the most important cost driver at all departments. The
osts for “labor” amounted to €1629 at department G but were fairly
imilar at the other departments (€711  115). Conclusions: Direct
osts of ICU days vary widely between the seven departments. Our
tandardized costing methodology could serve as a valuable instru-
ent to compare actual cost differences, such as those resulting from
ifferences in patient case-mix.
eywords: comparative study, cost analysis, costing methodology,
urope, intensive care.
opyright © 2012, International Society for Pharmacoeconomics and
utcomes Research (ISPOR). Published by Elsevier Inc.Introduction
Although intensive care unit (ICU) beds comprise less than 10% of
hospital beds, ICU departments consume 22% of total hospital
costs in the United States [1]. Also, the costs of ICU departments in
the Netherlands have been estimated to represent approximately
20% of the total hospital budget, with the costs per day between
three- and fivefold greater in ICU departments than in general
wards [2,3]. Therefore, several studies have assessed the costs of
ICU services. Cost estimations of ICU stay vary extensively. From a
multicenter German study, Moerer et al. [4] reported the total costs
per ICU day to be €855 (inflated to 2008). At the other extreme, the
total costs per day at ICU departments in the United States were
found to be €3221 (inflated to 2008) [5].
A number of studies have tried to explain actual cost differ-
ences between ICU departments [2,6,7]. The patient case-mix is
considered to have an important effect on the actual costs of ICU
days. Other potential factors influencing actual cost differences
include variations in study setting (e.g., bed occupancy rate, den-
sity of acute care beds, and staff composition), variations in med-
ical practice (emergency retrievals, referral pattern, and use of
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1098-3015/$36.00 – see front matter Copyright © 2012, Internation
Published by Elsevier Inc.mechanical ventilation), the availability of health-care resources
(e.g., the presence of a High Dependency Unit), the hospital pay-
ment system (e.g., public/private-mix and insurance payment),
and relative and absolute prices between countries [2,6]. It has
been argued, however, that some of the observed cost differences
are as a result of the methodologies used to estimate the costs
rather than being as a result of actual differences [7,8].
The application of a standardized costing methodology en-
ables a meaningful comparison of actual cost differences between
health-care services [9,10]. This way cost differences can be attrib-
uted to the health-care services under consideration, rather than
to differences in the costing methodology [11,12]. Yet, standard-
ized costing methodologies are often restricted by the availability
and quality of data. Resource quantities for individual patients are
generally not available with the same level of precision, even
within a single health-care provider’s clinical costing system and
systems vary markedly between health-care providers [13].
Several studies have made recommendations on the applica-
tion of standardized costing methodologies and potential bias for
the comparability between health-care services at different
health-care providers [13–15]. For example, Ritzwoller et al. [15]
ort.
chnology Assessment, Erasmus Universiteit Rotterdam, P.O. Box
ciety for Pharmacoeconomics and Outcomes Research (ISPOR).
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82 V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) 8 1 – 8 6attempted to identify comparable measures from the hospital in-
formation systems of seven health-care providers in the United
States to compare the health-care utilization of smokers, former
smokers, and never smokers. They found a substantial variation in
both the content and the capture of data across all health-care
providers and across all cost components.
Recommendations on the application of standardized costing
methodologies have also extensively been made in the field of ICU
stay [2,6,16]. A systematic literature review by Elliot [7] demon-
strated that the costing methodologies employed to calculate
costs of ICU stay are diverse and make comparative analyses be-
tween studies difficult. In their narrative review, Pines et al. [8]
have argued that despite considerable progress in costing meth-
odologies, critical care studies have not adequately implemented
these techniques.
The objective of the present study was to measure and com-
pare the direct costs of ICU days at seven ICU departments in
Germany, Italy, the Netherlands, and the United Kingdom by
means of a standardized costing methodology. Only one study in
the field of ICU stay has earlier applied a standardized costing
methodology across jurisdictions. Negrini et al. [17] developed a
standardized costing methodology and tested its feasibility at ICU
departments in France, Germany, Hungary, and the United King-
dom. A recognized limitation of their study was that estimates of
costs were permitted for some cost components, because cost data
were not always available at the ICU departments under consid-
eration. To overcome this limitation, the present study used a
standardized costing methodology that was based on the avail-
ability of data at the ICU departments under consideration.
Methods
The countries providing data to populate the study were Germany,
Italy, the Netherlands, and the United Kingdom. These countries
have participated in the center-randomized “real-life” study
ULTISAFE (see among others [18]). The aim was to select ICU de-
partments that were representative of the overall setting and
treatment patterns in the respective countries. Recruitment, how-
ever, was restricted by both hospitals’ willingness to participate
and time constraints. Hence, a retrospective cost analysis of ICU
patients was performed at seven ICU departments from the hos-
pital’s perspective. Department A involved the anesthesiological
adult ICU (12 beds) of the German focused-care (level III) hospital
“Klinik am Eichert” in Göppingen, at which all patients admitted
between January and October 2006 were recruited. In Italy, data
were collected at the medical-surgical adult ICU departments of
the “San Paolo Hospital” in Milan (department B; 6 beds) and of the
“Azienda Ospedaliera” in Padova (department C; 18 beds), at which
departments all patients admitted from January 2006 to January
2007 were included. In the Netherlands, costing studies were per-
formed at the medical-surgical adult ICU departments of the
“Erasmus MC University Medical Center” in Rotterdam (depart-
ment D; 32 beds; April–July 2006), the general university-affiliated
hospital “Gelre Hospitals” in Apeldoorn (department E; 10 beds;
Table 1 – Availability of data: Level of aggregation of the co
Department A Department B Departmen
BU/PL TD/DL BU/PL TD/DL BU/PL TD
Diagnostics x x x x
Consumables x x x x x x
Hotel and nutrition x x x x x x
Labor x x xBU/PL, bottom–up approach/patient level; TD/DL, top–down approach/depJanuary–July 2003), and the general university-affiliated hospital
“Isala clinics” in Zwolle (department F; 22 beds; November 2006).
With respect to department E, it was decided to retrospectively
collect data for a period of 6 months in 2003 owing to capacity
problems in the summers of 2006, 2005, and 2004. Department G
concerned the medical-surgical adult ICU (9 beds) of the British
“Royal Berkshire NHS Trust Hospital” in Reading, at which all pa-
tients admitted from April 2006 to April 2007 were recruited. The
patient samples of the recruited ICU departments showed some
actual differences at baseline that reflect the daily clinical practice.
A standardized costing methodology was employed to ensure
that the identified cost differences would reflect only actual cost
ifferences. A recognized limitation of the study of Negrini et al.
17] was that estimates of costs were permitted for some cost com-
onents, because cost data were not always available at the ICU
epartments under consideration. To overcome this limitation,
he present study used a standardized costing methodology that
as based on the availability of data at the ICU departments under
onsideration. Data concerned the four cost components: “diag-
ostics” (medical imaging and laboratory services), “consum-
bles” (drugs, fluids, and disposables), “hotel and nutrition,” and
labor” (ICU specialists, ICU nurses, and consulted specialists such
s medical specialists, pharmacists, physiotherapists, laboratory
echnicians, and nutrition specialists). Overheads were explicitly
xcluded from the cost analyses, because they are assumed to
ary widely between jurisdictions; that is, different parties may be
esponsible for the same cost item. For instance, where most cap-
tal costs of public hospitals are paid for by the state in Germany
nd do not represent any costs to the hospital, this was not the
ase in Italy, the Netherlands, or the United Kingdom.
For each of the cost components, either the bottom–up ap-
roach or the top–down approach was considered. The bot-
om–up approach is generally believed to be the preferred meth-
dology because it values each cost component for individual
atients. This enables statistical analyses to be made for the de-
ection of cost differences between patients and between cost
omponents [19–22]. The main drawback of the approach, how-
ver, is that it requires data at the patient level, which makes the
ata collection lengthy and expensive, especially when differ-
nces in coding systems exist [20,21]. The top–down approach is
ore feasible compared with the bottom–up approach, because it
equires data at the department level. Consequently, the top–
own approach values each cost component for average patients;
tatistical analyses of costs cannot be performed and differences
etween patients cannot be detected [9,14].
The crucial criterion for the choice between both approaches
as the level of aggregation in which resource-use data are avail-
ble (patient vs. department level). Table 1 depicts the level of
ggregation in which data are available at the seven departments.
or “diagnostics,” the level of aggregation varied between the pa-
ient level (departments A, D, E, and F) and the department level
departments B, C, and G). Even though resource quantities of
consumables” were generally deductable to the patient level, the
pplication of the bottom–up approach was impeded by the dif-
mponents per department.
Department D Department E Department F Department G
BU/PL TD/DL BU/PL TD/DL BU/PL TD/DL BU/PL TD/DL
x x x x x x x
x x x x x x x
x x x x x x x x
x x x xst co
t C
/DLartment level.
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83V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) 8 1 – 8 6ferent coding systems in place; application of the bottom–up ap-
proach would require the information from each of the systems to
be hand matched. Where resource quantities of “hotel and nutri-
tion” were structurally available at the patient level, those of “la-
bor” were not available at the patient level at any of the depart-
ments. In addition, wide variability existed in terms of training of
both ICU specialists and ICU nurses. Therefore, the standardized
costing methodology entailed the application of the bottom–up
approach for “hotel and nutrition” and the top–down approach for
“diagnostics,” “consumables,” and “labor.”
Resource quantities and unit costs of the cost components
were collected by using uniform reporting templates, which are
available to readers on request. Resource quantities of “diagnos-
tics,” “consumables,” and “hotel and nutrition” were derived from
computerized Patient Data Management Systems. Labor time
spent by ICU specialists, ICU nurses, and consulted specialists per
ICU day was determined by dividing the number of workable days
per year (taken from collective labor agreements) by the number of
ICU days per year (taken from computerized Patient Data Manage-
ment Systems). Unit costs represented the costs to the hospital
rather than wholesale prices. The unit costs of “diagnostics,” “con-
sumables,” and “hotel and nutrition” were primarily obtained
from hospital administrative databases. The unit costs of labor
were based on normative incomes (taken from hospital financial
databases) and allocated to patients according to the time spent
per ICU day. Normative incomes included wages, social premi-
ums, fees for irregular working hours, and the costs of replace-
ment during illness.
All costs were based on Euro 2008 cost data. All costs were
inflated to 2008 using the Eurostat harmonized indices of con-
sumer prices [23]. Mean exchange rates for 2008 were used. Statis-
tical analyses were conducted with the statistical software pro-
gram SPSS for Windows version 17.0. In all cases, P  0.05 was
taken as statistically significant.
Results
The patient samples of the seven ICU departments showed some
actual differences at baseline, which are summarized in Table 2. A
total of 2729 admissions of age 61  19 years with 60% male were
recorded, with an average of 390  232 per department. These
admissions related to 16,791 ICU days (2407 1607 on average per
department). The patient case-mix differed somewhat from de-
partment to department. The Simplified Acute Physiology Score
(SAPS) II ranged from 27 15 in department C to 42 20 in depart-
ent G. The share of mechanically ventilated patients varied be-
ween 33% at department C and 82% at department B. There were
higher proportion of patients with gastrointestinal diseases at
epartment A (31%), of cardiovascular diseases at department C
30%), department E (47%), and department F (33%), and of respi-
atory diseases at department B (37%) and department F (30%).
An overview of descriptive statistics at the department level is
iven in Table 3. Direct costs per ICU day varied between €1168
department B) and €2025 (department G). Labor was the key cost
river and entirely explained the increased costs at department G
€1629 compared with an average €711 at the other departments).
The costs for “diagnostics” were responsible for about 14% of
he direct costs and ranged from €99 at department G to €255 at
epartment D. Absolute costs of “laboratory services” were much
ower at department G (€56 compared with an average €145 at the
ther departments; P  0.030).
The costs for “consumables” were responsible for about 22% of
he direct costs and ranged from €241 at department B to €357 at
epartment F. The absolute costs of “fluids” predominantly repre-
ented blood (derived) products at departments A, B, C, and G,
hereas at departments D, E, and F they in addition comprised
rugs that were administered to the patient intravenously. There-T A G IC S M A IC *
Table 3 – The direct costs for an ICU day as determined by the standardized costing methodology23.
Department A
(n  400)
Department B
(n  448)
Department C
(n  756)
Department D
(n  242)
Department E
(n  304)
Department F
(n  30)
Department G
(n  549)
Total
population
Department
sample (n 7)
Mean SD
Diagnostic procedures
Medical imaging services 49 (4%) 45 (4%) 32 (2%) 60 (5%) 70 (5%) 124 (10%) 43 (2%) 60 (4%) 31
Laboratory services 132 (11%) 160 (14%) 129 (9%) 195 (16%) 130 (9%) 125 (10%) 56 (3%) 132 (10%) 42
Consumables
Drugs 115 (9%) 113 (10%) 210 (15%) 145 (12%) 151 (11%) 142 (11%) 113 (6%) 141 (10%) 34
Fluids 59 (5%) 51 (4%) 39 (3%) 131 (11%) 146 (10%) 151 (12%) 56 (3%) 90 (7%) 50
Disposables 74 (6%) 77 (7%) 71 (5%) 3 (0%) 33 (2%) 64 (5%) 117 (6%) 63 (5%) 36
Hotel and nutrition 80 (7%) 38 (3%) 25 (2%) 90 (8%) 86 (6%) 44 (3%) 11 (1%) 53 (4%) 32
Labor
ICU specialist 196 (16%) 257 (22%) 285 (21%) 150 (13%) 216 (15%) 256 (20%) 296 (15%) 237 (17%) 52
ICU nurse 445 (36%) 369 (32%) 561 (41%) 397 (33%) 562 (40%) 343 (27%) 1,123 (55%) 543 (39%) 270
Consulted specialist 80 (7%) 58 (5%) 33 (2%) 19 (2%) 20 (1%) 18 (1%) 210 (10%) 63 (5%) 69
Medical specialist 68 54 29 16 15 13 126 46 41
Pharmacist 1 0 0 1 1 0 6 1 2
Physiotherapist 6 4 4 0 1 1 55 10 20
Laboratory technician 4 0 0 1 3 3 18 4 6
Nutrition specialist 1 0 0 0 1 1 4 1 2
Total 1.230 1.168 1.385 1.190 1.414 1.267 2.025 1.383 298
ICU, intensive care unit.
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85V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) 8 1 – 8 6fore, the absolute costs of fluids were almost three times higher at
departments D, E, and F (€143 compared with an average €51 at the
other departments; P  0.001).
The costs for “hotel and nutrition” were responsible for only 4%
of the direct costs (€53  32).
Even though the distribution of costs varied by cost compo-
nent, labor was the most important cost driver at all departments.
The costs for “labor” amounted to €1629 at department G but were
fairly similar at the other departments (€711  115). The higher
abor costs at department G were predominantly explained by the
igher unit costs of ICU specialists (€92.40 compared with an av-
rage €65.90 per hour at the other departments; P 0.173) and ICU
urses (€51.00 compared with an average €26.90 per hour at the
ther departments; P  0.001; Table 4). In addition, the costs of
onsulted specialists were a manifold higher at department G
€210 vs. an average €38 at the other departments; P  0.002), es-
ecially for physiotherapists (26% of consultant specialists’ costs
s. an average 5% at the other departments; P  0.001). Overall,
edical specialists and physiotherapists were the greatest con-
ributors of consulted specialists’ costs.
Conclusions
Economic evaluations can provide health-care decision makers
with valuable information on the relative efficiency of alternative
health-care services, health-care services at different health-care
providers, and health-care services across jurisdictions. Because
of the wide range of costing methodologies applied, however, cost
assessments from different economic evaluations are often not
readily comparable or cannot be adjusted to a different context
[24,25]. Therefore, the present studies aimed to measure and com-
pare the costs of ICU days by means of a standardized costing
methodology. Direct costs per ICU day were €1383 398 but varied
between €1168 (department B) and €2025 (department G). Labor
was the key cost driver and entirely explained the increased costs
at department G (€1629 compared with an average €711 at the
other departments). Labor costs have previously been demon-
strated to be higher in the United Kingdom compared with other
European countries [17,26]. Negrini et al. [17] found the proportion
of labor to be 67% of the direct costs per day (compared with 61% in
our study), with hospitals in the United Kingdom being far more
costly than the hospitals in France, Germany, and Hungary.
The standardized costing methodology was based on the avail-
ability of data at the seven ICU departments. We believe, however,
that our sample of ICU departments is sufficiently representative
to assume that the established methodology is consistent as well
as generalizable to other settings. Although the bottom–up ap-
proach is generally believed to be the preferred methodology
[20,21], it was not applicable to “diagnostics,” “consumables,” and
“labor.” For “diagnostics,” patient-level data were not structurally
Table 4 – Hours spent per patient, unit costs and total cost
Department A
(n  400)
Department B
(n  448)
Departm
(n 
ICU specialist (mean daily
costs)
196 257 285
Resource quantities (h) 3.34 3.12 3.
Unit costs (€/h) 58.80 82.20 82.
ICU nurse (mean daily
costs)
445 369 561
Resource quantities (h) 13.23 14.64 22.
Unit costs (€/h) 33.60 25.20 25.
ICU, intensive care unit.available. For “consumables” and “labor,” patient-level data were bsubject to differences in coding systems. For example, drugs were
registered by drug category at some departments and by drug
name in others. Also, the same item, with the same name, may
have represented an entirely different concept at different depart-
ments. With respect to “labor,” wide variability existed in terms of
training of both ICU specialists and ICU nurses. For example, ICU
specialists at departments B and C generally have more responsi-
bilities compared with ICU specialists at the other departments
because there was a relative shortage of ICU nurses. At depart-
ments D, E, and F, ICU specialists included ICU residents. There-
fore, the standardized costing methodology entailed the applica-
tion of the bottom–up approach for “hotel and nutrition” and the
top–down approach for “diagnostics,” “consumables,” and “labor.”
If researchers studying other settings have access to data at the
patient level (bottom up), they must consider whether the benefit
of a more accurate cost estimate justifies restricted comparability/
generalizability incurred in using detailed information.
Earlier studies have proven that the top–down approach re-
sults in fairly accurate cost estimates [20–22]. To compare the cost
estimates resulting from the bottom–up and top–down ap-
proaches, we additionally determined the costs for “medical im-
aging services” by using the bottom–up approach for patients ad-
mitted between January 2006 and April 2006 at departments B and
C. This exercise did not result in significant cost differences for
medical imaging services (P 0.265). Likewise, the costs for the 25
most expensive drugs and disposables in terms of total expense
were additionally determined by using the bottom–up approach at
department A, but no significantly different results were observed
(Pmedications  0.373 and Pdisposables  0.285). The costs for “labor”
ere additionally determined by using the bottom–up approach at
epartment D (P  0.462). Thus, there is reason to believe that the
pplication of our standardized costing methodology resulted in
obust cost estimates.
The use of a standardized costing methodology is required to
e able to explain actual cost differences between ICU departments
n a straightforward way [7,8,17]. The patient samples of the re-
ruited ICU departments showed some actual differences at base-
ine that reflect the daily clinical practice. Some of these actual
ifferences may explain the actual cost differences we observed,
or example, the patient case-mix, variations in study setting (e.g.,
ensity of acute care beds), and variations in medical practice (e.g.,
se of mechanical ventilation [MV]). ICU departments in Germany
re used for postsurgery care. This was reflected by our German
epartment A, which included a higher proportion of patients
ith gastrointestinal diseases (31% compared with 12% on average
n the other countries). In addition, the density of acute care beds
er 1000 inhabitants is relatively high in Germany (6.4 compared
ith an average 2.9 in the other countries [23]). Similarly, it is likely
hat patients admitted to the ICU in the United Kingdom are more
everely ill and in need of more intensive care (density of acute care
he cost component labor23.
C Department D
(n  242)
Department E
(n  304)
Department F
(n  30)
Department G
(n  549)
150 216 256 296
3.57 3.57 3.68 3.20
42.00 60.60 69.60 92.40
397 562 343 1.123
15.39 21.78 13.30 22.02
25.80 25.80 25.80 51.00s of t
ent
756)
46
20
26
20eds: 2.3 [23]), which was reflected by the higher Simplified Acute
a
i
d
m
r
e
s
a
U
t
d
G
e
E
r
r
w
c
t
b
c
a
d
m
i
d
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
86 V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) 8 1 – 8 6Physiology Score II at our British department G (42 20). As a result,
actual differences might partly explain the lower costs at German
department A and the higher costs at British department G.
First ICU days have previously been demonstrated to be much
more expensive than subsequent ICU days [27]. Our study, how-
ever, did not distinguish between first and subsequent ICU days,
which may have falsely elevated cost variation between depart-
ments. The ICU length of stay varied widely between the seven
departments (range: from 3.8 at department F to 7.8 at department
A). Regression analyses performed at departments A, B, and D,
however, suggest that the ICU length of stay was unable to predict
daily ICU costs (R2  0.004).
Furthermore, several recent studies suggest that MV is associ-
ted with increased costs in the ICU [16,28]. Approximately 60% of
dentified patients were mechanically ventilated at some point
uring their ICU stay, but this share varied between 33% at depart-
ent C and 82% at department B. The actual difference in MV
ates, however, was not virtually reflected by actual cost differ-
nces. In Germany, patients requiring MV were 20% more expen-
ive than patients not requiring MV. These cost increases
mounted to 44% in Italy, 34% in the Netherlands, and 39% in the
nited Kingdom.
The country of treatment was clearly the most important fac-
or to explain the actual cost differences observed in this study. To
raw robust conclusions about actual cost differences between
ermany, Italy, the Netherlands, and the United Kingdom, how-
ver, a larger sample of ICU departments per country is needed.
ven though we attempted to select ICU departments that were
epresentative of the overall setting and treatment patterns in the
espective countries, recruitment was restricted by both hospitals’
illingness to participate and time constraints. Random sampling
ould also enhance the reliability of our results. Still, cross-coun-
ry cost comparisons in the field of ICU stay are scarce and thus we
elieve that our study provides valuable insight into the relative
osts in different European countries. Our results may be viewed
s preliminary data to support the funding of future studies to
etermine the generalizability of our results to other ICU depart-
ents within and beyond our sample of countries. Our standard-
zed costing methodology could serve as a valuable instrument to
etermine the generalizability of our results.
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